Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions (Q36605072)

15 August 2017

1 reference

title

Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions (English)

1 reference

15 August 2017

0 references

1 reference

Mufazzal Ahmad

1

1 reference

15 August 2017

Hemal Shah

series ordinal

2

1 reference

15 August 2017

Theodori Pliakogiannis

series ordinal

3

1 reference

15 August 2017

Dimitrios G Oreopoulos

series ordinal

4

1 reference

15 August 2017

publication date

27 September 2006

1 reference

International Urology and Nephrology

15 August 2017

published in

1 reference

15 August 2017

volume

39

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

299-312

1 reference

Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid.

15 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-006-9064-Y

Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-006-9064-Y

Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity

21 January 2018

1 reference

12 December 2020

Toxicity of osmotic solutes on human mesothelial cells in vitro

1 reference

12 December 2020

Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution.

1 reference

12 December 2020

Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.

1 reference

12 December 2020

In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity

1 reference

12 December 2020

Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS).

1 reference

12 December 2020

Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis

1 reference

12 December 2020

In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function

1 reference

12 December 2020

Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products

1 reference

12 December 2020

Decreased in vitro formation of AGEs with extraneal solution compared to dextrose-containing peritoneal dialysis solutions

1 reference

12 December 2020

Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function.

1 reference

12 December 2020

Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).

1 reference

12 December 2020

Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.

1 reference

12 December 2020

Simple peritoneal sclerosis and sclerosing peritonitis: related or distinct entities?

1 reference

12 December 2020

Biocompatibility studies on peritoneal cells

1 reference

12 December 2020

The effect of glucose polymers on water removal and protein clearances during CAPD

1 reference

12 December 2020

Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.

1 reference

12 December 2020

Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane

1 reference

12 December 2020

Glucose degradation products (GDP) retard remesothelialization independently of d-glucose concentration

1 reference

12 December 2020

Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane.

1 reference

12 December 2020

High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation

1 reference

12 December 2020

A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis

1 reference

12 December 2020

Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.

1 reference

12 December 2020

Peritoneal dialysis fluids induce the stress response in human mesothelial cells

1 reference

12 December 2020

Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious.

1 reference

12 December 2020

Pyruvate anions neutralize peritoneal dialysate cytotoxicity

1 reference

12 December 2020

Insulin efficacy with a new bicarbonate/lactate peritoneal dialysis solution

1 reference

12 December 2020

Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence

1 reference

12 December 2020

Renal fibrosis: insights into pathogenesis and treatment

1 reference

12 December 2020

Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum

1 reference

12 December 2020

Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival

1 reference

12 December 2020

European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions

1 reference

12 December 2020

Clinical evaluation of a peritoneal dialysis solution with 33 mmol/L bicarbonate

1 reference

12 December 2020

Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?

1 reference

12 December 2020

Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis

1 reference

12 December 2020

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload

1 reference

12 December 2020

Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD

1 reference

12 December 2020

Biocompatibility of a peritoneal dialysis solution with amino acids: histological evaluation in the rabbit

1 reference

12 December 2020

Histological and functional characteristics of peritoneal membrane in peritoneal sclerosis of PD patients

1 reference

12 December 2020

Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels

1 reference

12 December 2020

Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids

1 reference

12 December 2020

Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration

1 reference

12 December 2020

Possible role of hepatocyte growth factor in regeneration of human peritoneal mesothelial cells

1 reference

12 December 2020

Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure

1 reference

12 December 2020

Liver cell reactive components in peritoneal dialysis fluids

1 reference

12 December 2020

Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.

1 reference

12 December 2020

Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosis

1 reference

12 December 2020

Heat sterilization of glucose-containing fluids for peritoneal dialysis: biological consequences of chemical alterations.

1 reference

12 December 2020

Demonstration of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients.

1 reference

12 December 2020

Myofibroblastic conversion of mesothelial cells

1 reference

12 December 2020

Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid

1 reference

12 December 2020

Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro

1 reference

12 December 2020

Improved Acidosis Correction and Recovery of Mesothelial Cell Mass with Neutral-pH Bicarbonate Dialysis Solution among Children Undergoing Automated Peritoneal Dialysis

1 reference

12 December 2020

Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.

1 reference

12 December 2020

Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis

1 reference

12 December 2020

Morphologic changes in the peritoneal membrane of patients with renal disease

1 reference

12 December 2020

L-2-oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products

1 reference

12 December 2020

Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane.

1 reference

12 December 2020

Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.

1 reference

12 December 2020

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.

1 reference

12 December 2020

Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution

1 reference

12 December 2020

Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates

1 reference

12 December 2020

The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane

1 reference

12 December 2020

Different effects of amino acid-based and glucose-based dialysate from peritoneal dialysis patients on mesothelial cell ultrastructure and function

1 reference

12 December 2020

Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome

1 reference

12 December 2020

Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo

1 reference

12 December 2020

What really happens to people on long-term peritoneal dialysis?

1 reference

12 December 2020

Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain

1 reference

12 December 2020

Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro

1 reference

12 December 2020

Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se.

1 reference

12 December 2020

Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.

1 reference

12 December 2020

A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis

1 reference

12 December 2020

Peritoneal membrane morphology and function

1 reference

12 December 2020

Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats

1 reference

12 December 2020

Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.

1 reference

12 December 2020

Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent

1 reference

12 December 2020

Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

1 reference

12 December 2020

A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate/Lactate Study Group

1 reference

12 December 2020

Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo

1 reference

12 December 2020

Do interleukin-6, hyaluronan, soluble intercellular adhesion molecule-1 and cancer antigen 125 in dialysate predict changes in peritoneal function? A 1-year follow-up study

1 reference

12 December 2020

High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells

1 reference

12 December 2020

Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties

1 reference

12 December 2020

Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study

1 reference

12 December 2020

10.1007/S11255-006-9064-Y

Identifiers

DOI

1 reference

15 August 2017

1 reference